WallStreetZenWallStreetZen

NYSEMKT: ASXC
Asensus Surgical Inc Stock

$0.34+0.00 (+0%)
Updated Jul 18, 2024
ASXC Price
$0.34
Fair Value Price
N/A
Market Cap
$91.50M
52 Week Low
$0.20
52 Week High
$0.62
P/E
-1.12x
P/B
7.03x
P/S
7.1x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.72M
Earnings
-$78.71M
Gross Margin
-52%
Operating Margin
-899.16%
Profit Margin
-902.2%
Debt to Equity
2.13
Operating Cash Flow
-$60M
Beta
0.93
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ASXC Overview

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ASXC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ASXC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASXC is poor value based on its book value relative to its share price (7.03x), compared to the US Medical Devices industry average (3.83x)
P/B vs Industry Valuation
ASXC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ASXC due diligence checks available for Premium users.

Be the first to know about important ASXC news, forecast changes, insider trades & much more!

Valuation

ASXC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.12x
Industry
29.66x
Market
29.86x

ASXC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.03x
Industry
3.83x
ASXC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ASXC's financial health

Profit margin

Revenue
$1.1M
Net Income
-$22.5M
Profit Margin
-2,003.3%
ASXC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ASXC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$40.8M
Liabilities
$27.8M
Debt to equity
2.13
ASXC's short-term liabilities ($19.29M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASXC's short-term assets ($19.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASXC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ASXC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.0M
Investing
$3.0M
Financing
$811.0k
ASXC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ASXC vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
ASXC$91.50M-1.18%-1.12x7.03x
HYPR$89.29M+3.33%-2.10x1.18x
SRTS$96.88M+1.90%20.38x1.89x
XTNT$97.01M-4.36%-74.50x2.03x
ELUT$97.64M-0.74%-1.73x-1.94x

Asensus Surgical Stock FAQ

What is Asensus Surgical's quote symbol?

(NYSEMKT: ASXC) Asensus Surgical trades on the NYSEMKT under the ticker symbol ASXC. Asensus Surgical stock quotes can also be displayed as NYSEMKT: ASXC.

If you're new to stock investing, here's how to buy Asensus Surgical stock.

What is the 52 week high and low for Asensus Surgical (NYSEMKT: ASXC)?

(NYSEMKT: ASXC) Asensus Surgical's 52-week high was $0.62, and its 52-week low was $0.20. It is currently -45.81% from its 52-week high and 64.71% from its 52-week low.

How much is Asensus Surgical stock worth today?

(NYSEMKT: ASXC) Asensus Surgical currently has 272,331,675 outstanding shares. With Asensus Surgical stock trading at $0.34 per share, the total value of Asensus Surgical stock (market capitalization) is $91.50M.

Asensus Surgical stock was originally listed at a price of $2,073.50 in Dec 31, 1997. If you had invested in Asensus Surgical stock at $2,073.50, your return over the last 26 years would have been -99.98%, for an annualized return of -28.51% (not including any dividends or dividend reinvestments).

How much is Asensus Surgical's stock price per share?

(NYSEMKT: ASXC) Asensus Surgical stock price per share is $0.34 today (as of Jul 18, 2024).

What is Asensus Surgical's Market Cap?

(NYSEMKT: ASXC) Asensus Surgical's market cap is $91.50M, as of Jul 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Asensus Surgical's market cap is calculated by multiplying ASXC's current stock price of $0.34 by ASXC's total outstanding shares of 272,331,675.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.